Quipt Home Medical Corp. provided earnings guidance for the first quarter of fiscal year 2023. Based on the current operations (including sleep device impact), market trends and completed and prospective acquisitions, the Company is reiterating its outlook for its annual run-rate revenue by the end of calendar 2022 (Fiscal first quarter of 2023) to be $180-$190 million with $38-$43 million in Adjusted EBITDA.